new york, September 8, 2025 /PRNewswire/ -Vesey Street Capital Partners (“VSCP”) is a private equity company investing in middle market healthcare services companies, and announces it has added three members to the Strategic Advisory Board (SAB). Glenn Eisenberg, Todd Gustinand Chip Karn.
“We are thrilled to welcome Glenn, Todd and Chip to the Strategic Advisory Committee,” said the chairperson of the VSCP Strategic Advisory Committee. Dave King. “Glenn brings the leadership and financial expertise of decades of global public companies, leading leading companies like LABCORP and Timken through transformative growth. Todd's proven track record expands one of the nation's leading behavioral health pharmacy businesses, combined with deep experience in medical technology and investment banking. Make him one of the most respected voices in the industry.”
Glenn Eisenberg Most recently, he served as Executive Vice President and Chief Financial Officer at Labcorp. $13 As a billion global life sciences company, Glen has deep expertise in finance, strategy, operations and corporate governance. Previously he played senior roles at Timken Company and United Dominion Industries, and currently serves on the boards of several public and private companies. He is a current board member and is the audit committee chair for Solventum. Facilitating his extensive growth, carrying out complex transactions and leading the organization through transformation brings valuable perspectives to the advisory board.
Todd Gustin IS is the CEO of Genoa Healthcare, one of the nation's leading providers of pharmacy services for behavioral health, substance use disorders, and long-term care communities. With over 25 years of healthcare leadership experience, Todd has a proven record of expanding innovative businesses that deliver better patient outcomes and reduce costs. in front Genoahe played a senior executive role at Optum, where he promoted a strategy for growth and transformation in the technology and services sector. He previously spent over a decade on investment banking. Recognised as one of the top 50 healthcare technology CEOs of 2024, Todd brings both operational leadership and deep industry expertise to the board.
The story continues
